AVXL - CIK 0001314052
The table below shows ANAVEX LIFE SCIENCES CORP.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $102.58M | $132.19M | $151.02M | $149.16M | $152.11M | $29.25M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| - |
| - |
| - |
| Property, plant & equipment | - | - | - | - | - | - |
| Goodwill | - | - | - | - | - | - |
| Total assets | $103.81M | $135.57M | $154.39M | $152.70M | $161.62M | $34.54M |
| Accounts payable | $4.25M | $9.63M | $4.32M | $3.82M | $4.74M | $3.99M |
| Total current liabilities | - | - | - | - | - | - |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $8.95M | $15.30M | $12.53M | $10.21M | $10.80M | $7.31M |
| Retained earnings | -$382.45M | -$336.07M | -$293.07M | -$245.56M | -$197.59M | -$159.68M |
| Total equity | $94.87M | $120.26M | $141.85M | $142.49M | $150.82M | $27.24M |